Close Menu

eCase Study Videos

Displaying 1 - 10 of 10
Case Study

Probiotics Australia is the first TGA accredited, cGMP, certified organic, probiotic API manufacturer in Australia who strives to innovate and raise the standard of the industry by employing genomics in two main areas, regulatory and R & D.

To achieve the results needed within the required timeframe and in order for Probiotics Australia to remain at the forefront of the probiotic industry, the most logical and future-proof answer was high-throughput sequencing solutions, providing the ability to perform whole genome sequencing on single strains and metagenomic shotgun sequencing on mixed and community samples.

Tristrom Winsley of Probiotics Australia will discuss how they made the decision to bring this technology in-house and offer a scalable, cost effective solution for partners and collaborators.

Download a Transcript of this eCase Study here.

Sponsored by
Case Study

The rapid emergence of COVID-19 as a global pandemic affecting millions of individuals globally has necessitated sensitive and high-throughput approaches for the diagnosis, surveillance, and genetic epidemiology of SARS-CoV-2.

This presentation describes the application of the COVIDSeq assay as a high-sensitivity assay for detection of SARS-CoV-2, with an additional advantage of enabling genetic epidemiology and surveillance of SARS-CoV-2.

Download a Transcript of this eCase Study here.

Sponsored by
October 08, 2020
Sponsored by
Thermo Fisher Scientific

Optimized Protocol for Sequencing the SARS-CoV-2 Genome

Case Study

Strain identification and study of viral evolution is made more accurate by a workflow offered by Invitrogen for the study of SARS-CoV-2 and other viruses. The workflow is designed for flexibility to accommodate shifts in availability of components while providing strong viral coverage for sensitive SNP detection. In this eCase Study, Cris Kinross will give an overview of the workflow, demonstrate the coverage and variant detection achieved, and provide a link to the full optimized protocol

Download the companion Application Note here.

Download a Transcript of this eCase Study here.

Sponsored by
August 07, 2020
Sponsored by
Thermo Fisher Scientific

The challenge of sequencing SMN1/2 genes for spinal muscular atrophy research

Case Study

The most severe forms of spinal muscular atrophy (SMA) are considered to be a leading genetic cause of infant mortality. As a result, SMA is a very important disorder for carrier screening research studies. SMN1 and SMN2 are very similar in sequence: the functional difference between the two is a single nucleotide change—from a cytosine to a thymine in exon 7. This homology presents special challenges for NGS technologies commonly used in expanded carrier screening research. In this eCase study, Dr. Harris presents case examples to illustrate how the Ion Torrent™ CarrierSeq™ ECS Kits and algorithm advancements work in combination to detect SNVs and CNVs in these challenging genes.

Download a Transcript of this eCase Study here.

Sponsored by
June 23, 2020
Sponsored by
Thermo Fisher Scientific

Independent Evaluation of Reproseq PGS

Case Study

Whether you are expecting or one day hope to be, genetic screening can help empower informed decisions about how to move forward in the future. The goal of PGT-A, as a science, is to identify those embryos with the greatest potential of resulting in healthy outcomes. This on-demand video presents the resulsts of a head-to-head study performed with the Ion Torrent ReproSeq Assay compared to the Illumina Veriseq Assay. It details the high-resolution sequencing accuracy, data interpretation, and cost effectiveness of the ReproSeq Assay.

Download the transcript of this eCase Study here.

Sponsored by
June 16, 2020
Sponsored by
Thermo Fisher Scientific

The Challenge of Sequencing HBA1/2 Genes for Alpha Thalassemia Research

Case Study

Affecting approximately 5 percent of the world’s population, alpha thalassemia is the most common monogenic inherited disorder. Located in tandem, the HBA1 and HBA2 genes have identical coding sequences and this homology presents special challenges for NGS technologies commonly used in expanded carrier screening research.

In this presentation, Dr. Colin Davidson of Thermo Fisher Scientific presents case examples to illustrate how the Ion Torrent CarrierSeq ECS Kits and algorithm advancements work in combination to detect SNVs and CNVs in these challenging genes.

Download the transcript of this eCase Study here.

Sponsored by
April 14, 2020
Sponsored by
SeraCare

Rapid Implementation of SARS-CoV-2 Testing

Case Study

In this 15-minute, on-demand video, Dr. Joel Lefferts describes how his team at the Dartmouth-Hitchcock Medical Center were able to rapidly increase, through automation, their SARS-CoV-2 assay on the Abbott m2000. Dr. Lefferts provides practical experiences and challenges faced when developing, validating, and going live with a SARS-CoV-2 assay to facilitate patient testing.

Download the transcript to this eCase Study here.

Sponsored by
Case Study

In this 15-minute on-demand presentation, learn how Accuplex SARS-CoV-2 Reference Materials are meeting the immediate need for validating the performance of coronavirus assays. The focus of this presentation is on the technology, the importance of early detection, and helping every lab accelerate go-live-launch.

Download the transcript to this eCase Study here.

Sponsored by
April 14, 2020
Sponsored by
SeraCare

Experience with SARS-CoV-2 (COVID-19) Assay Validation

Case Study

In this 20-minute eCase Study you will hear first-hand how Dr. Jeff SoRelle and team, of the University of Texas Southwestern Medical Center, developed and validated a COVID-19 RT PCR assay. Dr. SoRelle shares his decision to bring this development in house, how he chose reference materials, and how he managed to scale up and provide rapid turnaround.

Download the transcript to this eCase Study here.

Sponsored by
Case Study
In this on-demand video presentation, Dr. Keith Gligorich, laboratory operations director at Navican Precision Cancer Care, discusses his experiences implementing a next-generation sequencing quality management system at Navican. 
 
Download the video to hear Dr. Gligorich explain the details of Navican's NGS quality management system and how it addresses the complexities of the precision medicine workflow.  
 
 
Sponsored by

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.